Dr Hemant Joshi

University of California, San Francisco, USA

Dr. Hemant Joshi is a dedicated molecular microbiologist with a deep commitment to addressing the global challenge of antimicrobial resistance. His research is rooted in unraveling the complex biology of Mycobacterium tuberculosis and other pathogenic bacteria to inform the development of novel therapeutics and improve treatment outcomes.

Currently serving as a Postdoctoral Researcher at the University of California, San Francisco (UCSF). Dr. Joshi investigates how pharmacological and genetic modulation of translational fidelity influence M. tuberculosis virulence, antibiotic tolerance, and drug resistance. His postdoctoral work bridges pharmacological and structural biology approaches—leveraging high resolution ribosome structures and collaborative antibiotic discovery efforts—to explore therapeutic potential of antimicrobials in tuberculosis. By understanding these factors, his research work has the potential to inform new diagnostic tools, optimize treatment regimens, and support more targeted public health strategies to combat tuberculosis. This research ultimately contributes to the global effort to reduce tuberculosis incidence and improve health outcomes in affected populations.

Dr. Joshi's journey in molecular microbiology began with a Ph.D. from Jawaharlal Nehru University, India, where he employed transposon mutagenesis to uncover genetic determinants of antibiotic tolerance and intracellular survival in Mycobacterium smegmatis. His doctoral research provided critical insights into bacterial persistence mechanisms, host-pathogen interactions, and biofilm biology—key elements of tuberculosis pathogenesis and treatment failure. In addition to his work on tuberculosis, Dr. Joshi has contributed to broader efforts in antimicrobial innovation. His interdisciplinary projects have included the development of green-synthesized metal nanoparticles with broad-spectrum antimicrobial activity and the design of nanoparticle-based biosensors for rapid pathogen detection.

Throughout his career, Dr. Joshi has been actively involved in mentoring young scientists and fostering interdisciplinary collaborations. He has been recognized with prestigious fellowships and travel awards from agencies such as CSIR, DBT, ICMR, and the Immunology Foundation. He is a member of the American Society for Microbiology and the Infectious Disease Society of America and is deeply engaged with the global scientific community through research, publication, and international conferences. Dr. Joshi’s commitment to translational microbiology, antibiotic discovery, and mentorship makes him a valuable contributor to scientific discourse. As an Associate Editor, he brings a keen understanding of both foundational science and clinical relevance, along with a collaborative spirit aimed at advancing solutions to some of the most pressing challenges in infectious disease research.

Updated 19 June 2025